Insider Selling: CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Sells 1,343,801 Shares of Stock

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Bioventures Opportunities G. Yk sold 1,343,801 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $0.08, for a total transaction of $107,504.08. Following the completion of the transaction, the insider now owns 17,618,618 shares in the company, valued at $1,409,489.44. The trade was a 7.09 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

CERo Therapeutics Price Performance

Shares of CERo Therapeutics stock traded down $0.01 during trading hours on Friday, hitting $0.06. The company’s stock had a trading volume of 31,185,395 shares, compared to its average volume of 20,494,506. The business has a fifty day moving average of $0.13 and a 200 day moving average of $0.22. CERo Therapeutics Holdings, Inc. has a 1-year low of $0.06 and a 1-year high of $12.80.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.